RE: Today RNS25 Feb 2026 15:40
Quick question tho Kal - why would anyone buy this, essentially valuing a pre clinical candidate at £40m… when you could buy CRTX which is under £10m & about to dose inhuman cancer trial, Phase 2. With registration grade certification (the very best and means likely don’t need to do P3)… ROQ is a ‘sort your mates out’ type deal and PIs get shat on - IMO